# Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia

> **NCT00722410** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 60 (estimated)

## Conditions studied

- Anti-Biotic Resistance
- Klebsiella Pneumoniae

## Interventions

- **DIETARY_SUPPLEMENT:** VSL#3
- **DRUG:** Polyethylene glycol

## Key facts

- **NCT ID:** NCT00722410
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2008-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00722410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00722410, "Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00722410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*